Year: 2023
-
US crypto industry lobby spending on track for new record in 2023
By Hannah Lang WASHINGTON (Reuters) – The cryptocurrency industry was on track to hit a new record for federal lobbying spending, after a year in which firms scrambled to repair their reputations and advance friendly legislation, according to data provided to Reuters by nonprofit research group OpenSecrets. Crypto companies spent $18.96 million in the first…
-
Boeing delivered 46 narrowbody 737s in November – sources
WASHINGTON (Reuters) – Boeing delivered 46 narrowbody 737s in November, sources told Reuters on Tuesday. Last month’s total brings Boeing’s single-aisle deliveries up to 351 units for the year so far, leaving the U.S. planemaker about 25 planes away from making its revised target for at least 375-400 737 deliveries this year. Last month’s 737…
-
Eli Lilly obesity drug now available in US pharmacies
By Patrick Wingrove and Manas Mishra (Reuters) -Eli Lilly on Tuesday said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies and could cost $550 a month for customers whose health insurance does not cover the drug, or half the list price. Zepbound is the latest entrant to the fast-growing market for…
-
Tel Aviv bourse says no unusual trading ahead of Oct 7 Hamas attack
By Steven Scheer JERUSALEM (Reuters) -The Tel Aviv Stock Exchange said on Tuesday that a report by U.S. researchers suggesting there were investors in Israel who may have profited from prior knowledge of Hamas’ Oct. 7 attack was inaccurate and its publication irresponsible. Research by law professors Robert Jackson Jr. from New York University and…
-
Binance might be peak for U.S. crypto enforcement cases, says CFTC official
By Huw Jones LONDON (Reuters) – Enforcement action against crypto firms may have peaked after last month’s $4.3 billion settlement with Binance, as such cases provide companies with a “template” for how they should be governed, a senior U.S. regulator said on Tuesday. Binance’s settlement with the Commodity Futures Trading Commission (CFTC) and Treasury Department,…
-
Alecta to lead class action against First Republic Bank
COPENHAGEN (Reuters) – Swedish pension fund Alecta said on Tuesday it had been appointed by a U.S. court to lead a class action against First Republic Bank aimed at recovering as much capital as possible that investors lost when the bank collapsed earlier this year. U.S. regulators on May 1 seized First Republic Bank and…
-
Trial over JetBlue’s Spirit merger ends with US judge mulling options
By Nate Raymond BOSTON (Reuters) -A federal judge considering the U.S. Justice Department’s bid to block JetBlue Airways’ proposed $3.8 billion acquisition of Spirit Airlines raised the possibility on Tuesday of letting the deal proceed if JetBlue divests more assets as the antitrust trial wrapped up. U.S. District Judge William Young told a JetBlue lawyer…
-
US job openings lowest in more than 2-1/2 years
By Lucia Mutikani WASHINGTON (Reuters) -U.S. job openings dropped to more than a 2-1/2-year low in October, the strongest sign yet that demand for labor was cooling amid higher interest rates. The Labor Department’s Job Openings and Labor Turnover Survey, or JOLTS report, on Tuesday also showed that there were 1.34 vacancies for every unemployed…
-
US bank bosses predict soft landing as consumers stay resilient
NEW YORK (Reuters) – U.S. bank chiefs expressed more confidence in the economic outlook for 2024 after consumers and businesses showed surprising strength this year. Here are quotes from the Goldman Sachs U.S. Financial Services Conference on Tuesday: David Solomon, Goldman Sachs CEO: “People continue to be cautious on the U.S. economy, but I think…
-
Eli Lilly extends tender offer deadline for Point Biopharma shares on low participation
(Reuters) – Eli Lilly on Monday again extended its deadline for Point Biopharma Global shareholders to sell their shares to the drugmaker, following low participation amid investor concerns that the offer price was low. Lilly set Dec. 15 as the deadline in a third extension. The Indianapolis-based drugmaker maintained its offer price at $12.50 per…